收费全文 | 31422篇 |
免费 | 1485篇 |
国内免费 | 199篇 |
耳鼻咽喉 | 322篇 |
儿科学 | 1070篇 |
妇产科学 | 641篇 |
基础医学 | 3925篇 |
口腔科学 | 1079篇 |
临床医学 | 2423篇 |
内科学 | 7894篇 |
皮肤病学 | 513篇 |
神经病学 | 2889篇 |
特种医学 | 1151篇 |
外科学 | 4887篇 |
综合类 | 131篇 |
一般理论 | 14篇 |
预防医学 | 1636篇 |
眼科学 | 420篇 |
药学 | 1807篇 |
中国医学 | 80篇 |
肿瘤学 | 2224篇 |
2023年 | 251篇 |
2022年 | 554篇 |
2021年 | 1048篇 |
2020年 | 558篇 |
2019年 | 833篇 |
2018年 | 1079篇 |
2017年 | 717篇 |
2016年 | 855篇 |
2015年 | 978篇 |
2014年 | 1228篇 |
2013年 | 1546篇 |
2012年 | 2498篇 |
2011年 | 2412篇 |
2010年 | 1456篇 |
2009年 | 1273篇 |
2008年 | 2065篇 |
2007年 | 2050篇 |
2006年 | 1912篇 |
2005年 | 1799篇 |
2004年 | 1609篇 |
2003年 | 1410篇 |
2002年 | 1402篇 |
2001年 | 200篇 |
2000年 | 130篇 |
1999年 | 198篇 |
1998年 | 231篇 |
1997年 | 203篇 |
1996年 | 188篇 |
1995年 | 177篇 |
1994年 | 137篇 |
1993年 | 154篇 |
1992年 | 92篇 |
1991年 | 80篇 |
1990年 | 104篇 |
1989年 | 83篇 |
1988年 | 73篇 |
1987年 | 60篇 |
1986年 | 70篇 |
1985年 | 58篇 |
1984年 | 77篇 |
1983年 | 67篇 |
1982年 | 78篇 |
1981年 | 58篇 |
1980年 | 70篇 |
1979年 | 39篇 |
1978年 | 50篇 |
1977年 | 39篇 |
1976年 | 38篇 |
1975年 | 38篇 |
1973年 | 38篇 |
Areas covered: This article covers the pharmacokinetics and pharmacodynamics of vilazodone and provides an evaluation of the clinical usefulness of vilazodone for the treatment of MDD and anxiety disorders. A literature search was performed using PubMed/MEDLINE, Web of Science and the Cochrane Library.
Expert opinion: Studies have shown that vilazodone is significantly superior to placebo. However, vilazodone cannot as yet be recommended as a first-line treatment option for MDD as it is unclear whether the drug’s dual mechanism of action provides greater efficacy than prevailing treatment options. Moreover, more phase IV studies are needed to establish its efficacy and long-term safety in larger and more diverse populations. Although vilazodone may have an additional advantage for the treatment of anxiety symptoms in MDD, here also additional studies are required to confirm its efficacy over and above SSRI alternatives and other antidepressant treatments. Therefore, presently, vilazodone should be considered as a second- or third-line treatment option for MDD and GAD. 相似文献
Background
Available models for predicting lymph node invasion (LNI) in prostate cancer (PCa) patients undergoing radical prostatectomy (RP) might not be applicable to men diagnosed via magnetic resonance imaging (MRI)-targeted biopsies.Objective
To assess the accuracy of available tools to predict LNI and to develop a novel model for men diagnosed via MRI-targeted biopsies.Design, setting, and participants
A total of 497 patients diagnosed via MRI-targeted biopsies and treated with RP and extended pelvic lymph node dissection (ePLND) at five institutions were retrospectively identified.Outcome measurements and statistical analyses
Three available models predicting LNI were evaluated using the area under the receiver operating characteristic curve (AUC), calibration plots, and decision curve analyses. A nomogram predicting LNI was developed and internally validated.Results and limitations
Overall, 62 patients (12.5%) had LNI. The median number of nodes removed was 15. The AUC for the Briganti 2012, Briganti 2017, and MSKCC nomograms was 82%, 82%, and 81%, respectively, and their calibration characteristics were suboptimal. A model including PSA, clinical stage and maximum diameter of the index lesion on multiparametric MRI (mpMRI), grade group on targeted biopsy, and the presence of clinically significant PCa on concomitant systematic biopsy had an AUC of 86% and represented the basis for a coefficient-based nomogram. This tool exhibited a higher AUC and higher net benefit compared to available models developed using standard biopsies. Using a cutoff of 7%, 244 ePLNDs (57%) would be spared and a lower number of LNIs would be missed compared to available nomograms (1.6% vs 4.6% vs 4.5% vs 4.2% for the new nomogram vs Briganti 2012 vs Briganti 2017 vs MSKCC).Conclusions
Available models predicting LNI are characterized by suboptimal accuracy and clinical net benefit for patients diagnosed via MRI-targeted biopsies. A novel nomogram including mpMRI and MRI-targeted biopsy data should be used to identify candidates for ePLND in this setting.Patient summary
We developed the first nomogram to predict lymph node invasion (LNI) in prostate cancer patients diagnosed via magnetic resonance imaging-targeted biopsy undergoing radical prostatectomy. Adoption of this model to identify candidates for extended pelvic lymph node dissection could avoid up to 60% of these procedures at the cost of missing only 1.6% patients with LNI. 相似文献Methods: In this prospective observational study, 15 volunteers underwent sciatic nerve examination using a curved ultrasound probe in the range of 2-5 MHz and a Philips-ATL 5000 unit (ATL Ultrasound, Bothell, WA) in the gluteal, infragluteal, and proximal thigh regions. Thereafter, an insulated block needle was advanced inline with the ultrasound beam to reach the nerve target, which was further confirmed by electrical stimulation. The quality of sciatic nerve images, ease of needle to nerve contact, threshold stimulating current, and resultant motor response were recorded.
Results: The sciatic nerve was successfully identified in the transverse view as a solitary predominantly hyperechoic structure on ultrasound in all of the three regions examined. The target nerve was visualized easily in 87% and localized within two needle attempts in all patients. Nerve stimulation was successful in 100% after two attempts with a threshold current of 0.42 +/- 0.12 (mean +/- SD) eliciting foot plantarflexion or dorsiflexion. 相似文献